Flexion Therapeutics — Q3 2019 Earnings Presentation
7 slides from Flexion Therapeutics's earnings presentation, Nov 7, 2019
Slide 1: Commercial Metrics Overview
Commercial Metrics Overview November 7, 2019 Exhibit 99.2
Slide 2: Commercial Metrics Overview
Commercial Metrics Overview ZILRETTA® net sales of $21.8 million in the third quarter of 2019 We have called on almost all of our 4,600 target accounts 3,130 accounts have purchased ZILRETTA, as of September 30, 2019; up from 2,733, as of June 30, 2019 2,344 accounts have re-ordered ZILRETTA (75% of
Slide 3: ZILRETTA Net Sales Quarterly
ZILRETTA Net Sales Quarterly Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy. Accounts (physicians, clinics and certain medical centers and hospitals) subsequently purchase ZILRETTA directly from these specialty distributors and the specialty pharmacy.
Slide 4: Distribution of Accounts by ZILRETTA Purchases
Distribution of Accounts by ZILRETTA Purchases Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy. Accounts (physicians, clinics and certain medical centers and hospitals) subsequently purchase ZILRETTA directly from these specialty distributors and
Slide 5: Distribution of ZILRETTA Purchases by Accounts
Distribution of ZILRETTA Purchases by Accounts Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy. Accounts (physicians, clinics and certain medical centers and hospitals) subsequently purchase ZILRETTA directly from these specialty distributors and
Slide 6: ZILRETTA Purchases by New and Existing Accounts
ZILRETTA Purchases by New and Existing Accounts Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy. Accounts (physicians, clinics and certain medical centers and hospitals) subsequently purchase ZILRETTA directly from these specialty distributors and
Slide 7: Flexion: Transformative Medicine Where It Matters
clevion Transformative Medicine... Where It Matters